Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1336 of 5804
-
New shot could help celiac patients who still suffer despite strict diet
Disease control OngoingThis is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a gluten free diet (GFD) with and without simulated inadve…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Nicotine swap helps smokers slash cigarettes in half
Disease control CompletedTo determine whether smokers who initially respond (within 2 weeks) to nicotine products (including nicotine replacement therapy, e-cigarettes, nicotine pouches) by reducing their smoking by ≥50% can be successfully maintained on use of these noncombustible nicotine alternatives …
Phase: PHASE3 • Sponsor: Rose Research Center, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a lower dose of this antibody tame Slow-Growing lymphoma?
Disease control Recruiting nowThis phase II trial tests the safety, side effects and effectiveness of mosunetuzumab in treating patients with slow growing (indolent) B-cell lymphoma. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread.
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New surgery aims to fix pelvic organ prolapse with fewer complications
Disease control OngoingPelvic organ prolapse in women is a common gynecological condition worldwide, with prevalence reported by different authors ranging from 15% to 50%. Up to 20% of women require surgical intervention during their lifetime due to genital prolapse or urinary incontinence. Surgical co…
Phase: NA • Sponsor: Riga East Clinical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Nerve zapping + exercise shows promise for spinal injury recovery
Disease control ENROLLING_BY_INVITATIONThis study is an open label extension of the SCI EFS clinical trial (NCT04288245) that developed an innovative strategy to enhance recovery of motor and sensory function after neurological injury. The objectives of this study are to provide continued safety assessment for the inv…
Phase: NA • Sponsor: The University of Texas at Dallas • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug shows promise for Crohn's sufferers in Mid-Stage trial
Disease control OngoingThis is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug aims to supercharge immune system against tough cancers
Disease control Recruiting nowStudy QXL138AM-001 is a Phase 1a/1b study to investigate the safety, pharmacokinetics, and preliminary activity of QXL138AM in subjects with locally advanced un-resectable and/or metastatic solid tumors and multiple myeloma. The study is an open-label, multicenter, first in human…
Phase: PHASE1 • Sponsor: Nammi Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo aims to shrink lung tumors in early trial
Disease control Recruiting nowPurpose of this study is to assess the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of volrustomig in combination with other anticancer drugs in participants with specified solid tumors.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New combo pill could tame stubborn diabetes
Disease control CompletedPhase 3 study to assess the Efficacy and Safety of CT-L03-301 in Type 2 Diabetes Patients with Insufficient Glycemic Control with Metformin and Empagliflozin Combination Therapy.
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a One-Week radiation blast beat three weeks for breast cancer?
Disease control Recruiting nowIn breast cancer patients with nodal involvement, numerous studies have demonstrated that adjuvant radiation therapy reduces the risk of local recurrence, regional recurrence, and distant metastases, in addition to improving survival. The dose and fractionation for adjuvant breas…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New psoriasis pill shows promise in Mid-Stage trial
Symptom relief CompletedTo assess the efficacy and safety of TQH3906 in subjects with moderate to severe plaque psoriasis, as well as the PK and PD characteristics of multiple doses
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Gene therapy injection aims to restore sight in rare eye diseases
Disease control OngoingA Phase 1, open-label, non-randomized, dose-escalation study, where approximately 18 eligible patients with retinitis pigmentosa or choroideremia will be enrolled sequentially in up to 4 dose cohorts of RTx-015. Enrolled patients will receive a single, unilateral intravitreal inj…
Phase: PHASE1 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
AI eye scanner could catch glaucoma before it steals your sight
Diagnosis CompletedThe goal of this observational study is to evaluate the clinical performance of VeriSee GLC for identifying glaucoma suspects using color fundus images in adult participants. The main questions it aims to answer are: * What are the sensitivity and specificity of VeriSee GLC for …
Sponsor: Acer Medical Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
AI spots baby seizures in home videos, could speed treatment
Knowledge-focused CompletedInfantile spasms are a type of seizure linked to developmental issues. Unfortunately, they are often misdiagnosed, causing delays in treatment. The purpose of this study is to develop a computer program that can reliably differentiate infantile spasms from similar, yet benign mov…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New drug mevidalen aims to ease Alzheimer's symptoms in 300-Person trial
Symptom relief CompletedThe main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), eve…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a mouth rinse save your taste buds during cancer treatment?
Symptom relief Recruiting nowThe purpose of this study is to identify preventive treatments that can minimize the occurrence, severity, and duration of talquetamab-related taste changes (dysgeusia), during the prophylaxis (preventive) treatment phase, to better characterize the signs or symptoms of talquetam…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New MS drug shows promise in reducing brain lesions
Disease control OngoingThis study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis
Phase: PHASE2 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
CBD oil tested for breast cancer drug side effect
Symptom relief TerminatedThis phase II trial tests the effectiveness of cannabidiol (CBD) plant extract (BRC-001) in improving joint stiffness and pain (arthralgia) in women with breast cancer taking aromatase inhibitors (AIs). AIs lower blood levels of estrogen in postmenopausal women to reduce breast c…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Can a protein shield your kidneys during Open-Heart surgery?
Disease control CompletedThe goal of this clinical trial is to identify the optimal dose of RMC-035 for protection of long-term renal function in adult patients undergoing cardiac surgery who are at high risk of kidney injury. It will also learn about the safety of RMC-035. The main question it aims to a…
Phase: PHASE2 • Sponsor: Guard Therapeutics AB • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could lavender oil ease PTSD? new trial aims to find out
Symptom relief Recruiting nowPosttraumatic stress disorder (PTSD) is a common and debilitating mental illness. Current treatments for PTSD include psychotherapy and antidepressant medications. Many patients are unable to tolerate psychotherapy for PTSD and drop out of it. In addition, its effectiveness is li…
Phase: PHASE3 • Sponsor: Deakin University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC